Cubist Systematic Strategies’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $3.9M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $2.83M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $389K | Buy |
|
|||||
|
2023
Q1 | $100K | Buy |
|
|||||
|
2022
Q4 | $69.4K | Buy |
|
|||||
|
2022
Q3 | $0 | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $430K | Sell |
|
|||||
|
2021
Q4 | $1.12M | Buy |
|
|||||
|
2021
Q3 | $1.18M | Sell |
|
|||||
|
2021
Q2 | $766K | Sell |
|
|||||
|
2021
Q1 | $517K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $214K | Buy |
|
|||||
|
2017
Q4 | $128K | Buy |
|
|||||
|
2017
Q3 | $101K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $45K | Sell |
|
|||||
|
2016
Q3 | $108K | Buy |
|
|||||
|
2016
Q2 | $91K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $171K | Sell |
|
|||||
|
2015
Q3 | $438K | Buy |
|
|||||
|
2015
Q2 | $237K | Sell |
|
|||||
|
2015
Q1 | $639K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $247K | Buy |
|